Critical evaluation of ceftolozane–tazobactam for complicated urinary tract and intra-abdominal infections

Autor: Giancola SE, Mahoney MV, Bias TE, Hirsch EB

Publikováno v: Therapeutics and Clinical Risk Management, Vol 2016, Iss Issue 1, Pp 787-797 (2016)

Stephanie E Giancola,1 Monica V Mahoney,2 Tiffany E Bias,3,4 Elizabeth B Hirsch2,51Department of Pharmacy, St Mary’s Medical Center, Huntington, WV, 2Beth Israel Deaconess Medical Center, Boston, MA, 3Hahnemann University Hospital, 4Drexel Universi

Externí odkaz: https://doaj.org/article/efd9edfabc3946c0a04bff02587c8cf0

A Bundle of the "Top 10" Outpatient Parenteral Antimicrobial Therapy Publications in 2023.

Autor: Childs-Kean LM; College of Pharmacy, University of Florida, Gainesville, Florida, USA., Beieler AM; Infectious Diseases Clinic, Harborview Medical Center, Seattle, Washington, USA., Cortés-Penfield N; Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA., Keller SC; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Rivera CG; Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA., Ryan KL; Department of Pharmacy, University of New Mexico Hospital, Albuquerque, New Mexico, USA., Yoke LH; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, Washington, USA.; Allergy and Infectious Disease Division, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA., Mahoney MV; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Oct 29; Vol. 11 (11), pp. ofae635. Date of Electronic Publication: 2024 Oct 29 (Print Publication: 2024).

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study.

Autor: Rebold N; Wayne State University, Detroit, MI, USA. nicholas.rebold@howard.edu.; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI, 48201, USA. nicholas.rebold@howard.edu.; Department of Clinical and Administrative Pharmacy Sciences, College of Pharmacy, Howard University, 2300 4th St NW, Office 114, Washington, DC, 20059, USA. nicholas.rebold@howard.edu., Alosaimy S; Wayne State University, Detroit, MI, USA.; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI, 48201, USA., Pearson JC; Department of Pharmacy, Brigham and Women's Hospital, Boston, MA, USA., Dionne B; Department of Pharmacy, Brigham and Women's Hospital, Boston, MA, USA.; School of Pharmacy, Northeastern University, Boston, MA, USA., Taqi A; Department of Pharmacy, Brigham and Women's Hospital, Boston, MA, USA., Lagnf A; Wayne State University, Detroit, MI, USA.; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI, 48201, USA.; Detroit Medical Center, Detroit Receiving Hospital, Detroit, MI, USA., Lucas K; Wayne State University, Detroit, MI, USA.; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI, 48201, USA., Biagi M; College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA.; Department of Pharmacy, Swedish American Health System, Rockford, IL, USA., Lombardo N; Department of Pharmacy, Swedish American Health System, Rockford, IL, USA., Eudy J; Department of Pharmacy, Augusta University Medical Center, Augusta, GA, USA., Anderson DT; Department of Pharmacy, Augusta University Medical Center, Augusta, GA, USA., Mahoney MV; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA., Kufel WD; Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY, USA.; Department of Pharmacy Practice, Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, NY, USA., D'Antonio JA; Department of Pharmacy Practice, Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, NY, USA., Jones BM; Department of Pharmacy, St. Joseph's/Candler Health System, Savannah, GA, USA., Frens JJ; Department of Pharmacy, Moses H. Cone Memorial Hospital, Cone Health, Greensboro, NC, USA., Baumeister T; Department of Pharmacy, Moses H. Cone Memorial Hospital, Cone Health, Greensboro, NC, USA., Geriak M; Sharp Memorial Hospital, Sharp Healthcare, San Diego, CA, USA., Sakoulas G; Sharp Rees-Stealy Medical Group, San Diego, CA, USA.; University of California San Diego School of Medicine, Division of Host-Microbe Systems and Therapeutics, La Jolla, CA, USA., Farmakiotis D; Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA.; Transplant and Oncology Infectious Diseases, Rhode Island Hospital, Providence, RI, USA., Delaportas D; Mon Health Medical Center, Morgantown, WV, USA., Larew J; Mon Health Medical Center, Morgantown, WV, USA., Veve MP; Wayne State University, Detroit, MI, USA.; College of Pharmacy, University of Tennessee, Knoxville, TN, USA.; Department of Pharmacy, Henry Ford Health System, Detroit, MI, USA., Rybak MJ; Wayne State University, Detroit, MI, USA. m.rybak@wayne.edu.; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI, 48201, USA. m.rybak@wayne.edu.; Detroit Medical Center, Detroit Receiving Hospital, Detroit, MI, USA. m.rybak@wayne.edu.; School of Medicine, Wayne State University, Detroit, MI, USA. m.rybak@wayne.edu.

Publikováno v: Infectious diseases and therapy [Infect Dis Ther] 2024 Mar; Vol. 13 (3), pp. 565-579. Date of Electronic Publication: 2024 Mar 01.

Impact of a pharmacy resident on a transitions of care rotation for inpatients enrolled in an outpatient parenteral antimicrobial therapy (OPAT) program.

Autor: Britt RS; Department of Pharmacy, The University of Texas Medical Branch at Galveston, Galveston, Texas., Pearson JC; Department of Pharmacy, Brigham & Women's Hospital, Boston, Massachusetts., LaSalvia MT; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Mahoney MV; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts., McCoy C; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Padival S; Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Publikováno v: Antimicrobial stewardship & healthcare epidemiology : ASHE [Antimicrob Steward Healthc Epidemiol] 2023 Jun 29; Vol. 3 (1), pp. e111. Date of Electronic Publication: 2023 Jun 29 (Print Publication: 2023).

Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review.

Autor: Johnson TM; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA., Byrd TF; Division of Infectious Diseases, University of New Mexico, Albuquerque, NM, USA., Drummond WK; Division of Infectious Diseases, Providence Portland Medical Center, Portland, OR, USA., Childs-Kean LM; College of Pharmacy, University of Florida, Gainesville, FL, USA., Mahoney MV; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA., Pearson JC; Department of Pharmacy Services, Brigham and Women's Hospital, Boston, MA, USA., Rivera CG; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA. Rivera.Christina@mayo.edu.

Publikováno v: Infectious diseases and therapy [Infect Dis Ther] 2023 Feb; Vol. 12 (2), pp. 343-365. Date of Electronic Publication: 2023 Jan 07.